Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay

Naoko Nose, Rudolf A. Werner, Yuichiro Ueda, Katharina Günther, Constantin Lapa, Mehrbod S. Javadi, Kazuhito Fukushima, Frank Edenhofer, Takahiro Higuchi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Recent developments in cellular reprogramming technology enable the production of virtually unlimited numbers of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). Although hiPSC-CM share various characteristic hallmarks with endogenous cardiomyocytes, it remains a question as to what extent metabolic characteristics are equivalent to mature mammalian cardiomyocytes. Here we set out to functionally characterize the metabolic status of hiPSC-CM in vitro by employing a radionuclide tracer uptake assay. Material and methods: Cardiac differentiation of hiPSC was induced using a combination of well-orchestrated extrinsic stimuli such as WNT activation (by CHIR99021) and BMP signalling followed by WNT inhibition and lactate based cardiomyocyte enrichment. For characterization of metabolic substrates, dual tracer uptake studies were performed with 18 F‑2‑fluoro‑2‑deoxy‑D‑glucose ( 18 F-FDG) and 125 I‑β‑methyl‑iodophenyl‑pentadecanoic acid ( 125 I-BMIPP) as transport markers of glucose and fatty acids, respectively. Results: After cardiac differentiation of hiPSCs, in vitro tracer uptake assays confirmed metabolic substrate shift from glucose to fatty acids that was comparable to those observed in native isolated human cardiomyocytes. Immunostaining further confirmed expression of fatty acid transport and binding proteins on hiPSC-CM. Conclusions: During in vitro cardiac maturation, we observed a metabolic shift to fatty acids, which are known as a main energy source of mammalian hearts, suggesting hi-PSC-CM as a potential functional phenotype to investigate alteration of cardiac metabolism in cardiac diseases. Results also highlight the use of available clinical nuclear medicine tracers as functional assays in stem cell research for improved generation of autologous differentiated cells for numerous biomedical applications.

Original languageEnglish
Pages (from-to)229-234
Number of pages6
JournalInternational Journal of Cardiology
Volume269
DOIs
Publication statusPublished - Oct 15 2018
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Cardiac Myocytes
Radioisotopes
Fatty Acids
Fatty Acid Transport Proteins
Metabolic Equivalent
Stem Cell Research
Glucose
Fatty Acid-Binding Proteins
In Vitro Techniques
Clinical Medicine
Nuclear Medicine
Heart Diseases
Lactic Acid
Technology
Phenotype
Acids

Keywords

  • Cardiomyocytes
  • Fatty acid
  • hiPSC-CM
  • Induced pluripotent stem cells
  • Stem cell therapy
  • Tracer

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation : Functional assessment using in vitro radionuclide uptake assay. / Nose, Naoko; Werner, Rudolf A.; Ueda, Yuichiro; Günther, Katharina; Lapa, Constantin; Javadi, Mehrbod S.; Fukushima, Kazuhito; Edenhofer, Frank; Higuchi, Takahiro.

In: International Journal of Cardiology, Vol. 269, 15.10.2018, p. 229-234.

Research output: Contribution to journalArticle

Nose, Naoko ; Werner, Rudolf A. ; Ueda, Yuichiro ; Günther, Katharina ; Lapa, Constantin ; Javadi, Mehrbod S. ; Fukushima, Kazuhito ; Edenhofer, Frank ; Higuchi, Takahiro. / Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation : Functional assessment using in vitro radionuclide uptake assay. In: International Journal of Cardiology. 2018 ; Vol. 269. pp. 229-234.
@article{2fa3ff5ca6164082b82e5a6a4e4e2312,
title = "Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation: Functional assessment using in vitro radionuclide uptake assay",
abstract = "Background: Recent developments in cellular reprogramming technology enable the production of virtually unlimited numbers of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). Although hiPSC-CM share various characteristic hallmarks with endogenous cardiomyocytes, it remains a question as to what extent metabolic characteristics are equivalent to mature mammalian cardiomyocytes. Here we set out to functionally characterize the metabolic status of hiPSC-CM in vitro by employing a radionuclide tracer uptake assay. Material and methods: Cardiac differentiation of hiPSC was induced using a combination of well-orchestrated extrinsic stimuli such as WNT activation (by CHIR99021) and BMP signalling followed by WNT inhibition and lactate based cardiomyocyte enrichment. For characterization of metabolic substrates, dual tracer uptake studies were performed with 18 F‑2‑fluoro‑2‑deoxy‑D‑glucose ( 18 F-FDG) and 125 I‑β‑methyl‑iodophenyl‑pentadecanoic acid ( 125 I-BMIPP) as transport markers of glucose and fatty acids, respectively. Results: After cardiac differentiation of hiPSCs, in vitro tracer uptake assays confirmed metabolic substrate shift from glucose to fatty acids that was comparable to those observed in native isolated human cardiomyocytes. Immunostaining further confirmed expression of fatty acid transport and binding proteins on hiPSC-CM. Conclusions: During in vitro cardiac maturation, we observed a metabolic shift to fatty acids, which are known as a main energy source of mammalian hearts, suggesting hi-PSC-CM as a potential functional phenotype to investigate alteration of cardiac metabolism in cardiac diseases. Results also highlight the use of available clinical nuclear medicine tracers as functional assays in stem cell research for improved generation of autologous differentiated cells for numerous biomedical applications.",
keywords = "Cardiomyocytes, Fatty acid, hiPSC-CM, Induced pluripotent stem cells, Stem cell therapy, Tracer",
author = "Naoko Nose and Werner, {Rudolf A.} and Yuichiro Ueda and Katharina G{\"u}nther and Constantin Lapa and Javadi, {Mehrbod S.} and Kazuhito Fukushima and Frank Edenhofer and Takahiro Higuchi",
year = "2018",
month = "10",
day = "15",
doi = "10.1016/j.ijcard.2018.06.089",
language = "English",
volume = "269",
pages = "229--234",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Metabolic substrate shift in human induced pluripotent stem cells during cardiac differentiation

T2 - Functional assessment using in vitro radionuclide uptake assay

AU - Nose, Naoko

AU - Werner, Rudolf A.

AU - Ueda, Yuichiro

AU - Günther, Katharina

AU - Lapa, Constantin

AU - Javadi, Mehrbod S.

AU - Fukushima, Kazuhito

AU - Edenhofer, Frank

AU - Higuchi, Takahiro

PY - 2018/10/15

Y1 - 2018/10/15

N2 - Background: Recent developments in cellular reprogramming technology enable the production of virtually unlimited numbers of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). Although hiPSC-CM share various characteristic hallmarks with endogenous cardiomyocytes, it remains a question as to what extent metabolic characteristics are equivalent to mature mammalian cardiomyocytes. Here we set out to functionally characterize the metabolic status of hiPSC-CM in vitro by employing a radionuclide tracer uptake assay. Material and methods: Cardiac differentiation of hiPSC was induced using a combination of well-orchestrated extrinsic stimuli such as WNT activation (by CHIR99021) and BMP signalling followed by WNT inhibition and lactate based cardiomyocyte enrichment. For characterization of metabolic substrates, dual tracer uptake studies were performed with 18 F‑2‑fluoro‑2‑deoxy‑D‑glucose ( 18 F-FDG) and 125 I‑β‑methyl‑iodophenyl‑pentadecanoic acid ( 125 I-BMIPP) as transport markers of glucose and fatty acids, respectively. Results: After cardiac differentiation of hiPSCs, in vitro tracer uptake assays confirmed metabolic substrate shift from glucose to fatty acids that was comparable to those observed in native isolated human cardiomyocytes. Immunostaining further confirmed expression of fatty acid transport and binding proteins on hiPSC-CM. Conclusions: During in vitro cardiac maturation, we observed a metabolic shift to fatty acids, which are known as a main energy source of mammalian hearts, suggesting hi-PSC-CM as a potential functional phenotype to investigate alteration of cardiac metabolism in cardiac diseases. Results also highlight the use of available clinical nuclear medicine tracers as functional assays in stem cell research for improved generation of autologous differentiated cells for numerous biomedical applications.

AB - Background: Recent developments in cellular reprogramming technology enable the production of virtually unlimited numbers of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). Although hiPSC-CM share various characteristic hallmarks with endogenous cardiomyocytes, it remains a question as to what extent metabolic characteristics are equivalent to mature mammalian cardiomyocytes. Here we set out to functionally characterize the metabolic status of hiPSC-CM in vitro by employing a radionuclide tracer uptake assay. Material and methods: Cardiac differentiation of hiPSC was induced using a combination of well-orchestrated extrinsic stimuli such as WNT activation (by CHIR99021) and BMP signalling followed by WNT inhibition and lactate based cardiomyocyte enrichment. For characterization of metabolic substrates, dual tracer uptake studies were performed with 18 F‑2‑fluoro‑2‑deoxy‑D‑glucose ( 18 F-FDG) and 125 I‑β‑methyl‑iodophenyl‑pentadecanoic acid ( 125 I-BMIPP) as transport markers of glucose and fatty acids, respectively. Results: After cardiac differentiation of hiPSCs, in vitro tracer uptake assays confirmed metabolic substrate shift from glucose to fatty acids that was comparable to those observed in native isolated human cardiomyocytes. Immunostaining further confirmed expression of fatty acid transport and binding proteins on hiPSC-CM. Conclusions: During in vitro cardiac maturation, we observed a metabolic shift to fatty acids, which are known as a main energy source of mammalian hearts, suggesting hi-PSC-CM as a potential functional phenotype to investigate alteration of cardiac metabolism in cardiac diseases. Results also highlight the use of available clinical nuclear medicine tracers as functional assays in stem cell research for improved generation of autologous differentiated cells for numerous biomedical applications.

KW - Cardiomyocytes

KW - Fatty acid

KW - hiPSC-CM

KW - Induced pluripotent stem cells

KW - Stem cell therapy

KW - Tracer

UR - http://www.scopus.com/inward/record.url?scp=85049358264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049358264&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2018.06.089

DO - 10.1016/j.ijcard.2018.06.089

M3 - Article

C2 - 30224033

AN - SCOPUS:85049358264

VL - 269

SP - 229

EP - 234

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -